Imatinib promotes apoptosis of giant cell tumor cells by targeting microRNA-30a-mediated runt‑related transcription factor 2

  • Authors:
    • Yuxiang Liao
    • Guohua Lv
    • Bing Wang
    • Lei Kuang
    • Xiaobin Wang
  • View Affiliations

  • Published online on: December 28, 2015     https://doi.org/10.3892/mmr.2015.4722
  • Pages: 1739-1745
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Giant cell tumor (GCT) is an aggressive type of bone tumor consisting of multinucleated osteoclast‑like giant cells. Imatinib is a selective inhibitor for certain type III tyrosine kinase receptor family members with a variety of beneficial effects. The purpose of the present study was to determine the therapeutic potential and underlying mechanism of imatinib against GCT. In the present study, cell viability and apoptosis in GCT were analyzed using the MTT assay, flow cytometry and DAPI staining assay. Caspase‑3 and ‑9 activity in GCT cells were analyzed with colorimetric assay kits. In addition, the expression levels of runt‑related transcription factor 2 (RunX2) protein and microRNA‑30a (miR‑30a) in GCT cells were detected using western blotting and quantitative polymerase chain reaction, respectively. Results from the present study demonstrated that imatinib treatment inhibited cell viability, increased cell apoptosis, and significantly promoted caspase‑3 and ‑9 activity in GCT. In addition, imatinib treatment decreased the RunX2 protein expression level. Notably, imatinib was demonstrated to increase miR‑30a expression. However, upregulation of miR‑30a expression reduced the RunX2 protein expression level, and downregulation of miR‑30a expression reversed the anticancer effect of imatinib on GCT, increasing the expression level of RunX2 protein in GCT. The results of the present study indicate that imatinib promotes apoptosis of GCT cells by targeting the miR‑30a‑mediated RunX2 signaling pathway.
View Figures
View References

Related Articles

Journal Cover

February-2016
Volume 13 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liao Y, Lv G, Wang B, Kuang L and Wang X: Imatinib promotes apoptosis of giant cell tumor cells by targeting microRNA-30a-mediated runt‑related transcription factor 2. Mol Med Rep 13: 1739-1745, 2016
APA
Liao, Y., Lv, G., Wang, B., Kuang, L., & Wang, X. (2016). Imatinib promotes apoptosis of giant cell tumor cells by targeting microRNA-30a-mediated runt‑related transcription factor 2. Molecular Medicine Reports, 13, 1739-1745. https://doi.org/10.3892/mmr.2015.4722
MLA
Liao, Y., Lv, G., Wang, B., Kuang, L., Wang, X."Imatinib promotes apoptosis of giant cell tumor cells by targeting microRNA-30a-mediated runt‑related transcription factor 2". Molecular Medicine Reports 13.2 (2016): 1739-1745.
Chicago
Liao, Y., Lv, G., Wang, B., Kuang, L., Wang, X."Imatinib promotes apoptosis of giant cell tumor cells by targeting microRNA-30a-mediated runt‑related transcription factor 2". Molecular Medicine Reports 13, no. 2 (2016): 1739-1745. https://doi.org/10.3892/mmr.2015.4722